AI Found the Trial Patient. That Was the Easy Part.
AI can identify clinical-trial candidates faster. The harder test is whether patients are contacted, enrolled, and able to complete the journey.
The 72-Hour Promise
Newly released records from Medicare’s WISeR pilot show why AI-assisted prior authorization must be judged by timely, appropriate, completed care—not decision speed alone.
The Scan Is Not the Finish Line
AI can spot a suspicious lung nodule. The harder question is whether the health system can carry the patient from that signal to completed care.
Healthcare | Hormonal & Endocrine Health | Longevity Research | Nutrition & Metabolic Health | Peptides, Metabolic Health & Longevity Therapeutics
Longevity Claims, Decoded: What GLP-1s and Peptides Actually Prove
A scientific claim decoder for separating human outcomes from biomarkers, animal evidence, mechanisms, and marketing around GLP-1s, peptides, and longevity therapies.
The Gray Market Is Not a GLP-1 Care Path
How to distinguish accountable GLP-1 care from counterfeit products, research-use peptides, illegal online sellers, and poorly disclosed compounded offers.
Before You Believe a GLP-1 Claim, Find Its Place on the Evidence Ladder
A seven-rung evidence ladder for separating FDA labels, clinical trials, real-world evidence, sponsor reports, testimonials, and unapproved GLP-1 sales claims.
The Metabolic-Drug Pipeline Is Not a Pharmacy Shelf
How to distinguish published trial evidence, regulatory review, FDA approval, and unapproved sales in the fast-moving metabolic-drug pipeline.
The AI Second Reader That Changed the Chart
A large liver-cancer study shows what happened after an AI system found overlooked lesions: reports changed, cases escalated, and care pathways moved—without yet proving better patient outcomes.
Healthcare | Nutrition & Metabolic Health | Peptides, Metabolic Health & Longevity Therapeutics | Pharma
The GLP-1 Trust Test: What an Online Provider Should Be Willing to Show You
Eight source-backed questions for checking an online GLP-1 provider’s clinical accountability, medication category, pharmacy, follow-up, claims, price, and commercial influence.
Healthcare | Nutrition & Metabolic Health | Peptides, Metabolic Health & Longevity Therapeutics | Pharma
Read the Label Before the GLP-1 Link: A Disclosure Decoder
A plain-language guide to affiliate, paid-placement, medication-category, price, and evidence disclosures on GLP-1 pages.
